|
|
Lakefront Biotherapeutics
AMS •
Healthcare •
Biotechnology •
Quote as of 06/23/2026 17:35
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeAMS
Market Capitalization1,589.44 mln
Float44.54 mln
Earnings Date08/10/2026
P / E
3.42
Deeply undervalued
1-Year Forecast
30.15
Attractive
Relative Strength
89
/ 100
Strongly outperforming
Key Fundamentals
EPS7.41
P/E3.42
ROE17.06
RPS15.84
ROIC98.51
ROA13.48
Interest Cover848
EBITDA, mln398
EV / EBITDA-3.48
EV / EBIT-3.48
Revenue, mln1,044
EV / Revenue-1.33
Financial Strength
Altman Z-Score9.93
Piotroski F-Score
6
/ 9
Beneish M-Score0.58
Price to Graham Number0.24
1-Year Target Price30.15
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
5.14% |
98
/ 100
 |
| 1 Month |
5.67% |
95
/ 100
|
|
| |
